FOS and lung carcinoma: Taking into account the abundance of Jun- and Fos-specific fragments in exDNA content in the blood of LLC-bearing mice and the 2.5–3-fold increased level of these fragments in comparison with healthy mice, these genes can be proposed as possible markers of malignant diseases, particularly for detection of lung cancer.